# Mitochondria Lead the Way: Mitochondrial Dynamics and Function in Cellular Movements in Development and Disease

**Authors:** Somya Madan, Bhavin Uttekar, Sayali Chowdhary, Richa Rikhy

PMC · DOI: 10.3389/fcell.2021.781933 · Frontiers in Cell and Developmental Biology · 2022-02-02

## TL;DR

This review explores how mitochondria influence cell shape changes during development and disease by regulating their dynamics and activity.

## Contribution

The paper synthesizes recent findings on mitochondrial roles in cell morphogenesis and highlights the need for mechanistic analysis.

## Key findings

- Mitochondrial shape is regulated to support cell shape dynamics and morphogenesis.
- Mitochondria release metabolites and buffer molecules that influence signaling pathways.
- Understanding mitochondrial-cell shape interactions could reveal common principles in development and disease.

## Abstract

The dynamics, distribution and activity of subcellular organelles are integral to regulating cell shape changes during various physiological processes such as epithelial cell formation, cell migration and morphogenesis. Mitochondria are famously known as the powerhouse of the cell and play an important role in buffering calcium, releasing reactive oxygen species and key metabolites for various activities in a eukaryotic cell. Mitochondrial dynamics and morphology changes regulate these functions and their regulation is, in turn, crucial for various morphogenetic processes. In this review, we evaluate recent literature which highlights the role of mitochondrial morphology and activity during cell shape changes in epithelial cell formation, cell division, cell migration and tissue morphogenesis during organism development and in disease. In general, we find that mitochondrial shape is regulated for their distribution or translocation to the sites of active cell shape dynamics or morphogenesis. Often, key metabolites released locally and molecules buffered by mitochondria play crucial roles in regulating signaling pathways that motivate changes in cell shape, mitochondrial shape and mitochondrial activity. We conclude that mechanistic analysis of interactions between mitochondrial morphology, activity, signaling pathways and cell shape changes across the various cell and animal-based model systems holds the key to deciphering the common principles for this interaction.

## Full-text entities

- **Genes:** si:busm1-180o5.2 (si:busm1-180o5.2) [NCBI Gene 368517] {aka E-cadherin, cdh1, si:dz180o5.2}, sqh (spaghetti squash) [NCBI Gene 31554] {aka CG3595, DmMRLC_C, Dmel\CG3595, MLC, MLRC, MRLC}, rhoa.L (ras homolog family member A L homeolog) [NCBI Gene 379416] {aka arha, rhoa, rhoa-a, rhoa-b, xrhoa}, cdkn1a.L (cyclin-dependent kinase inhibitor 1A L homeolog) [NCBI Gene 492305] {aka cdkn1a, cip1, p16Xic2, p21}, akt1.S (AKT serine/threonine kinase 1 S homeolog) [NCBI Gene 399170] {aka akt-1, pkb, rac, v-akt, v-akt1, xAct}, MCU (mitochondrial calcium uniporter) [NCBI Gene 90550] {aka C10orf42, CCDC109A, HsMCU}, VIM (vimentin) [NCBI Gene 7431], Col4a1 (Collagen type IV alpha 1) [NCBI Gene 33727] {aka CG25C, CG4145, CT12803, Cg25C, Cg25c, Cgc25}, sfrp2 (secreted frizzled-related protein 2) [NCBI Gene 566878] {aka hm:zeh0225, hm:zeh0225r, sb:eu233, zeh0225, zgc:153618}, Rac1 (Rac family small GTPase 1) [NCBI Gene 19353] {aka D5Ertd559e}, Fis1 (fission, mitochondrial 1) [NCBI Gene 66437] {aka 2010003O14Rik, Ttc11}, NKRF (NFKB repressing factor) [NCBI Gene 55922] {aka ITBA4, NRF, XTBD3}, opa1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 492332] {aka fk62d06, wu:fb77a10, wu:fk62d06, zgc:92092}, hpo (hippo) [NCBI Gene 37247] {aka CG11228, Dmel\CG11228, Hippo, Hpo/Wts, MST, MST2}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, prkaa2.S (protein kinase, AMP-activated, alpha 2 catalytic subunit S homeolog) [NCBI Gene 399172] {aka ampk, ampk2, prkaa, prkaa1, prkaa2}, PXN (paxillin) [NCBI Gene 5829], src.L (SRC proto-oncogene, non-receptor tyrosine kinase L homeolog) [NCBI Gene 380430] {aka c-src, csrc, pp60c-src, pp60v-src, src, src-1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, myo19.S (myosin XIX S homeolog) [NCBI Gene 734396] {aka myo19}, MST1 (macrophage stimulating 1) [NCBI Gene 4485] {aka D3F15S2, DNF15S2, HGFL, MSP, NF15S2}, ROCK1 (Rho associated coiled-coil containing protein kinase 1) [NCBI Gene 6093] {aka P160ROCK, ROCK-I}, Catalase [NCBI Gene 100174793], mcu.L (mitochondrial calcium uniporter L homeolog) [NCBI Gene 100037005] {aka ccdc109a, mcu}, Rhot1 (ras homolog family member T1) [NCBI Gene 59040] {aka 2210403N23Rik, Arht1, C430039G08Rik, Miro1}, rac1.L (Rac family small GTPase 1 L homeolog) [NCBI Gene 734382] {aka Xrac, mig5, p21-rac1, rac, rac1, tc-25}, Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, Snph (syntaphilin) [NCBI Gene 241727] {aka 6430515A01, mKIAA0374}, ins.S (insulin S homeolog) [NCBI Gene 378696] {aka ins-a, ins-b, ins1, ins1-a, xins}, PXN (paxillin) [NCBI Gene 517456], Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}, MFN-1 [NCBI Gene 101109233], mfn2.L (mitofusin 2 L homeolog) [NCBI Gene 431918] {aka mfn2}, Src64B (Src oncogene at 64B) [NCBI Gene 48973] {aka C-src1, CG7524, D-Src64B, D-src, DSRC64, DSrc}, cdk1.L (cyclin-dependent kinase 1 L homeolog) [NCBI Gene 379785] {aka MPF, PSTAIR, cdc-2, cdc2, cdc2-b, cdc28a}, actl6a.S (actin like 6A S homeolog) [NCBI Gene 380143] {aka actin, actl6, actl6a, actl6a.L, arp4, arpn-beta}, tnf.L (tumor necrosis factor L homeolog) [NCBI Gene 100137625] {aka dif, tnf, tnf-alpha, tnfa, tnfsf2, xtnf}, Opa1 (OPA1, mitochondrial dynamin like GTPase) [NCBI Gene 74143] {aka 1200011N24Rik, lilr3, mKIAA0567}, dnm1a (dynamin 1a) [NCBI Gene 100307098] {aka dnm1, si:dkey-246l19.2}, Drp1 (Dynamin related protein 1) [NCBI Gene 33445] {aka CG3210, DNM1L, DRP, Dmel\CG3210, Dnm1/Drp1, Drp}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], mapk1.S (mitogen-activated protein kinase 1 S homeolog) [NCBI Gene 398985] {aka erk, erk1, erk2, ert1, mapk, mapk1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, bcl2.S (B-cell CLL/lymphoma 2 S homeolog) [NCBI Gene 100271914] {aka bcl-2, bcl2, xBcl-2, xbcl2}, kif5b.S (kinesin family member 5B S homeolog) [NCBI Gene 100101320] {aka khc, kif5b}, Sod1 (Superoxide dismutase 1) [NCBI Gene 39251] {aka 24492, CG11793, Cu, Cu-Zn SOD, Cu-Zn-SOD, Cu/Zn SOD}, ACTE1 (actin epsilon 1) [NCBI Gene 528168], ptk2.L (protein tyrosine kinase 2 L homeolog) [NCBI Gene 399286] {aka FAK, XPFAK, fak1, ptk2}, Pten (Phosphatase and tensin homolog) [NCBI Gene 43991] {aka CG5671, D.PTEN, DPTEN, Dmel\CG5671, PTEN3, dPTEN}, tnfa (tumor necrosis factor a (TNF superfamily, member 2)) [NCBI Gene 405785], pak1.S (p21 protein (Cdc42/Rac)-activated kinase 1 S homeolog) [NCBI Gene 398126] {aka X-PAK1, XPak1, pak, pak-1, pak1, pak1.L}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, mapk8.L (mitogen-activated protein kinase 8 L homeolog) [NCBI Gene 379876] {aka jnk, jnk1, mapk8, sapk1, xJNK}, snph.S (syntaphilin S homeolog) [NCBI Gene 100037009] {aka snph}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, catalase [NCBI Gene 101093891], mmp9.2.L (matrix metallopeptidase 9 gene 2 L homeolog) [NCBI Gene 100037129] {aka mmp-9th, mmp9, mmp9.L, mmp9th}, shg (shotgun) [NCBI Gene 37386] {aka CADH, CG3722, CT12481, Cad, CadE, Cadh}
- **Diseases:** triple-negative breast cancer (MESH:D064726), Metastasis (MESH:D009362), Mitochondrial fragmentation (MESH:D012892), Inflammation (MESH:D007249), pancreatic ductal carcinoma (MESH:D021441), Embryonic lethality (MESH:D020964), ovarian cancer (MESH:D010051), placental defects (MESH:D010922), Breast cancer (MESH:D001943), hypoxic (MESH:D002534), non-small lung cancer (MESH:D002289), Lung injury (MESH:D055370), cancer (MESH:D009369), Mitochondrial transport defects (MESH:C565376), mitochondrial apoptosis (MESH:D028361), infection (MESH:D007239), aneuploidy (MESH:D000782), bleeding (MESH:D006470), Hypoxia (MESH:D000860), mitochondrial fission (OMIM:614388), colorectal carcinomas (MESH:D015179), tailfin injury (MESH:D014947), coagulation (MESH:D001778), hepatocellular carcinoma (MESH:D006528), shoulder tendon injuries (MESH:D000070599), bone defect (MESH:D001847), epithelial injury (MESH:D009375), Ischemia (MESH:D007511), lethality (MESH:C536057), rectal cancer (MESH:D012004), kidney injury (MESH:D007674), lung cancer (MESH:D008175)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Scorpiones (scorpions, order) [taxon 6855], Danio rerio (leopard danio, species) [taxon 7955], C. elegans [taxon 328850], Gallus gallus (bantam, species) [taxon 9031], Sus scrofa (pig, species) [taxon 9823], Cricetus cricetus (black-bellied hamster, species) [taxon 10034], Rattus norvegicus (brown rat, species) [taxon 10116], Asteroidea (sea stars, class) [taxon 7588], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Paracentrotus lividus (common sea urchin, species) [taxon 7656], Xenopus laevis (African clawed frog, species) [taxon 8355], Caenorhabditis elegans (species) [taxon 6239], Mus musculus (house mouse, species) [taxon 10090], Ovis aries (domestic sheep, species) [taxon 9940], Drosophila melanogaster (fruit fly, species) [taxon 7227]
- **Cell lines:** MDA-MB-435 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0417), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), Hs578t — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0332), HIC-5 — Homo sapiens (Human), Transformed cell line (CVCL_B0J8)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8848284/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8848284/full.md

## References

346 references — full list in the complete paper: https://tomesphere.com/paper/PMC8848284/full.md

---
Source: https://tomesphere.com/paper/PMC8848284